People · Operator
Named in public records as an officer, director or promoter · active 2019–2021 · Pharma, Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Century Therapeutics, Inc. | — | Pharma | Series D+ | $160.0M | $4.7B | 2021 |
| Vineti, Inc. | — | Biotechnology | Series C | $115.7M | $2.8B | 2020 |
| Cedilla Therapeutics, Inc. | — | Biotechnology | Series C | $82.6M | $3.1B | 2020 |
| C2i Genomics, Inc. | — | Biotechnology | Series C | $62.0M | $1.5B | 2020 |
| Singular Bio, Inc. | — | Biotech / Pharma | Series A | $6.6M | $220.3M | 2019 |
| Sexton Biotechnologies, Inc. | — | Biotechnology | Series A | $5.0M | $180.8M | 2019 |
Eli Casdin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eli Casdin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nina Kjellson | 1 | 11 |
| Emily Melton | 1 | 10 |
| Risa Stack | 1 | 9 |
| Carlo Rizzuto | 1 | 7 |
| Rowan Chapman | 1 | 7 |
| Jake Simson | 1 | 6 |
| ABBIE CELNIKER | 1 | 6 |
| NEIL EXTER | 1 | 5 |
| Alexandra Glucksmann | 1 | 4 |
| Michael Pellini | 1 | 4 |
| Chris Bowden | 1 | 3 |
| Chris Krueger | 1 | 3 |
| Juergen Eckhardt | 1 | 3 |
| Cynthia Butitta | 1 | 3 |
| Shaun Rodriguez | 1 | 3 |
| Joseph Jimenez | 1 | 3 |
| Amy DuRoss | 1 | 2 |
| Ezra Sofer | 1 | 2 |
| Mike Rice | 1 | 2 |
| Alex Parker | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.